Amount$20M
SeriesStrategic
AnnouncedSep 20, 2022
Time since last round265 mo
SectorHealthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection, Indication Expansion, Drug Development, Pharmaceuticals, Biotech
Sub-sectorMachine Learning, Natural Language Processing, Artificial Intelligence
Solid
A solid round with healthy fundamentals.
Round size vs peers
Larger than the typical Strategic round (2.4×).
Syndicate size
Single investor — limited external validation.
Insider conviction
1 existing investor re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Strategic rounds (48)
Round size distribution77th pct
smaller Strategic roundslarger
vs. Healthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection, Indication Expansion, Drug Development, Pharmaceuticals, Biotech (5)
Round size in sector80th pct
$4Mthis round: $20M$20M
